Common Acid Reflux Drugs Linked to Possible Higher Dementia Risk in Long-Term Users
A widely used group of medications for acid reflux and heartburn may be associated with a higher risk of dementia when taken over a long period, researchers have suggested.
The medications are known as proton pump inhibitors, or PPIs. They include commonly prescribed drugs such as Omeprazole, Lansoprazole, and Pantoprazole.
These medicines are often used to reduce stomach acid and relieve symptoms linked to acid reflux and heartburn. Doctors typically recommend taking them once daily for a limited period, depending on the patient’s condition and treatment plan.
However, questions have continued to grow around the possible effects of long-term use. Over time, extended use of PPIs has been associated with several potential side effects, including a possible increased risk of dementia.
Researchers Examine Long-Term PPI Use
A 2023 study found that people who used proton pump inhibitors for an extended period were 33 percent more likely to develop dementia.
The research examined data from 5,712 adults between the ages of 45 and 64. None of the participants had dementia when the study began.
Nearly 1,500 people in the study were taking PPIs, representing about 26 percent of the total group.
Researchers then looked at patterns among those using the medications and compared outcomes while accounting for factors such as age, race, sex, and existing health conditions.
The findings suggested a link between longer use of the medications and a higher chance of later developing dementia. However, researchers stressed that the study did not prove the drugs directly caused dementia.
Omeprazole and Other PPIs Under Scrutiny
Omeprazole is one of the best-known medications in the PPI category, but the discussion also includes Lansoprazole and Pantoprazole.
These medications work by reducing the amount of acid produced in the stomach. For many people, they provide important relief from symptoms that can interfere with daily life, including burning discomfort, indigestion, and reflux.
Because they are widely used, even a possible long-term risk can draw significant attention.
Many patients take these medicines under medical guidance, while others may remain on them for longer than originally intended because symptoms return when treatment stops.
The new concerns do not mean every person taking a PPI will develop dementia. Instead, the research points to a possible association that experts say requires further study.
What the Study Found
Among the participants studied, researchers identified 497 people who had taken PPIs for roughly four and a half years.
Of those long-term users, 58 later developed dementia.
After adjusting for several other possible influences, researchers observed a pattern suggesting that extended use of PPIs was linked with a higher dementia risk.
Neurologist Dr Kamakshi Lakshminarayan emphasized that the study should not be misunderstood as proof that the medications directly cause dementia.
“This study does not prove that acid reflux drugs cause dementia,” neurologist Dr Kamakshi Lakshminarayan said, according to LadBible. “It only shows an association.
“More research is needed to confirm our findings in other large study groups and understand the possible link between long-term proton pump inhibitor use and higher risk of dementia.
“While we did not find a link with short-term use, we did find a higher risk of dementia associated with long-term use of these drugs.”
Association Does Not Mean Proof
The distinction between association and causation is important in medical research.
An association means two things appear connected in the data. It does not necessarily mean one directly causes the other.
In this case, people who used PPIs for a long time had a higher rate of dementia, but the study does not prove that the medication itself caused the condition.
Other health factors, medical histories, lifestyle patterns, or underlying conditions could also influence the results.
This is why researchers called for more investigation in other large groups. Confirming a possible link requires repeated findings, deeper analysis, and a clearer understanding of how the medications might affect the body or brain over time.
For now, the study raises a concern rather than delivering a final answer.
Possible Role of Vitamin B12
Researchers have considered several possible explanations for why long-term PPI use might be linked to dementia risk.
One theory involves vitamin B12.
Dr. Lakshminarayan explained that some studies have shown an association between acid reflux medications and lower B12 levels.
“Some studies have shown that use of acid reflux drugs may be associated with low B12 levels,” Dr. Lakshminarayan explained. “And low B12 is associated with impaired thinking and poor memory.”
Vitamin B12 plays an important role in the nervous system and brain function. Low levels have been connected with problems involving thinking and memory.
However, Dr. Lakshminarayan also noted that she could not comment directly on this theory in relation to the study because B12 levels were not measured among the participants.
That means the possible B12 explanation remains a theory rather than a confirmed mechanism in this specific research.
Amyloid Theory Also Discussed
Another possible explanation involves amyloid, a protein strongly linked to Alzheimer’s disease.
Dr. Gregory Day, an associate professor in the Department of Neurology at the Mayo Clinic, said the theory remains plausible.
He reportedly explained that PPIs may affect enzymes in the brain that help regulate amyloid.
According to him, the medications may “decrease the level of the body’s chemical that is there to cut off the amyloid in specific ways.”
“In theory, these medications increase amyloid in the brain, increasing the risk of Alzheimer’s disease, and Alzheimer’s is the number one cause of dementia,” he said.
This idea suggests a possible biological pathway that could help explain the association seen in long-term users.
However, as with the B12 theory, more research is needed before experts can say with certainty whether this mechanism plays a direct role.
Why Dementia Risk Matters
Dementia is a major health concern because it affects memory, thinking, behavior, and the ability to carry out daily activities.
Alzheimer’s disease is the most common cause of dementia, and researchers continue studying possible risk factors that may influence brain health over time.
When a commonly used medication is associated with a possible increased risk, the finding naturally attracts attention from patients and healthcare providers.
PPIs are used by many people, often for symptoms that are uncomfortable but manageable with different treatment approaches.
That does not mean patients should panic or immediately stop taking their medication.
Instead, the findings suggest that long-term use should be discussed carefully with a healthcare professional, especially when a person has been taking the medication for months or years.
Short-Term Use Was Not Linked in the Study
One important part of the study is that researchers did not find a link with short-term use.
The concern was associated with long-term use, particularly among people who had taken PPIs for roughly four and a half years.
This distinction matters for people who use these medications temporarily to manage symptoms under medical advice.
A short course of treatment is different from extended use over several years.
Doctors may prescribe PPIs for limited periods, and many patients take them only during active symptoms or specific treatment windows.
The findings suggest that the duration of use may be an important factor in evaluating possible risk.
Patients Should Not Stop Suddenly
Despite the study’s findings, experts warn that patients should not abruptly stop taking prescribed PPIs without speaking to a doctor.
Stopping the medication suddenly may cause symptoms to worsen, especially for people who rely on it to control acid reflux.
Dr. Lakshminarayan emphasized the importance of medical guidance before making changes.
“While there are various ways to treat acid reflux, such as taking antacids, maintaining a healthy weight, and avoiding late meals and certain foods, different approaches may not work for everyone,” Dr. Lakshminarayan said.
“It is important that people taking these medications speak with their doctor before making any changes, to discuss the best treatment for them, and because stopping these drugs abruptly may result in worse symptoms.”
The message is clear: concerns about long-term risks should lead to a conversation with a medical professional, not sudden self-directed changes.
Other Ways to Manage Acid Reflux
Acid reflux can sometimes be managed through several approaches, though not every method works for every person.
Some people may use antacids to help relieve symptoms. Others may benefit from maintaining a healthy weight, avoiding late meals, or identifying foods that appear to trigger reflux symptoms.
These strategies may reduce the need for long-term medication in some cases, but they are not universal solutions.
For certain patients, PPIs may remain the most effective option, especially when symptoms are persistent or when a doctor believes acid control is medically necessary.
This is why individualized treatment matters.
The best approach depends on a person’s symptoms, medical history, risk factors, and response to different treatments.
Balancing Benefits and Possible Risks
PPIs can provide significant relief for people dealing with acid reflux and heartburn.
For many patients, the medications improve quality of life by reducing pain, discomfort, and disruption caused by stomach acid.
At the same time, long-term use should be reviewed periodically, especially in light of research suggesting possible associations with health risks.
The goal is not to frighten patients away from medication they may need. The goal is to ensure that treatment remains appropriate, effective, and monitored.
A doctor may decide that continued use is necessary. In other cases, a patient may be able to reduce dosage, switch treatments, or explore lifestyle changes under medical supervision.
The key issue is informed decision-making.
What Patients Should Ask Their Doctors
People who have been using Omeprazole, Lansoprazole, Pantoprazole, or other PPIs for a long time may want to discuss the duration of treatment with their doctor.
They may ask whether continued use is still necessary, whether the dose remains appropriate, and whether alternative strategies could help manage symptoms.
Patients may also ask whether any monitoring is recommended, particularly if they have concerns about nutrition, memory, or long-term health.
These conversations should be calm and practical rather than driven by fear.
The study does not prove that PPIs cause dementia, but it does raise enough concern that long-term users may want to review their treatment plan.
Medical guidance is especially important for people with severe reflux symptoms or other health conditions.
More Research Is Needed
Researchers have made clear that more studies are necessary to confirm the findings and better understand the possible relationship between long-term PPI use and dementia risk.
Future research may examine larger groups, measure factors such as B12 levels, and explore possible effects on amyloid regulation in the brain.
Such work could help determine whether the observed association reflects a direct drug effect, an indirect biological pathway, or other factors linked to long-term PPI use.
Until then, the findings should be interpreted carefully.
They are important enough to discuss, but not definitive enough to justify panic.
The most responsible response is to use the information as a reason for medical review, especially for people who have been taking PPIs continuously for years.
A Cautious Message for Long-Term Users
The possible link between long-term proton pump inhibitor use and dementia risk has raised concern because these medications are so common.
Omeprazole, Lansoprazole, and Pantoprazole are widely used for acid reflux and heartburn, often with good results.
The 2023 study found that extended users were 33 percent more likely to develop dementia, but experts emphasize that this does not prove the drugs cause dementia.
Possible explanations involving low B12 levels and amyloid regulation have been discussed, but more research is needed to confirm any mechanism.
For patients, the most important takeaway is not to stop medication suddenly.
Anyone concerned about long-term PPI use should speak with a doctor, review their treatment plan, and discuss the safest way to manage acid reflux symptoms going forward.